UBS AM
MDLN

UBS AM’s Medline Inc MDLN Stock Holding History

UBS AM’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112M Buy
2,829,363
+1,561,083
+123% +$62.9M 0.02% 502
2026
Q1 		$56.4M Buy
1,268,280
+846,573
+201% +$37.4M 0.01% 596
2025
Q4 		$17.7M Buy
+421,707
New +$17.8M ﹤0.01% 893

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

UBS AM's MDLN Position: Q2 2026 in Review

UBS AM increased its Medline Inc (MDLN) stake by 123% in Q2 2026, buying an estimated $62.9M and bringing the position to 2,829,363 shares worth $112M. The position accounts for 0.02% of the portfolio, ranked #502.

UBS AM first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. 280 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • UBS AM held 2,829,363 shares of Medline Inc worth $112M as of Q2 2026.
  • UBS AM bought 1,561,083 Medline Inc shares in Q2 2026, an estimated $62.9M.
  • Medline Inc made up 0.02% of UBS AM's portfolio in Q2 2026, its #502 holding.
  • UBS AM first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • 280 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.